There is research on this stock available only to PRO subscribers.
We currently have no Breaking News on this stock.
BMRN vs. ETF Alternatives
Biomarin Pharmaceutical Inc develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its product portfolio is comprised of five product candidates Naglazyme, Kuvan, Aldurazyme, VIMIZIM and Firdapse.
Other News & PR